Search results

745 results

Sorted by Relevance . Sort by Date

In development Remove In development filter
Proposed Remove Proposed filter
In consultation Remove In consultation filter
Technology appraisal guidance Remove Technology appraisal guidance filter
Interventional procedures guidance Remove Interventional procedures guidance filter
Highly specialised technologies guidance Remove Highly specialised technologies guidance filter
Public health guidelines Remove Public health guidelines filter

Ixazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (CDF review of TA505) [ID1635]

Proposed [GID-TA10781] Expected publication date: 22 September 2021

Type

Technology appraisal guidance

Status

Proposed
Liposomal bupivacaine for treating postoperative pain [ID3799]

Proposed [GID-TA10681] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Remimazolam for sedation for people having diagnostic or therapeutic procedures [ID3758]

Proposed [GID-TA10720] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Fostemsavir for treating adults with multidrug resistant HIV-1 for whom it is not possible to construct a suppressive anti-viral regimen [ID2726]

Proposed [GID-TA10605] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Abrocitinib for treating moderate to severe atopic dermatitis in people aged 12 and over [ID3768]

Proposed [GID-TA10764] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Semaglutide for managing overweight and obesity [ID3850]

Proposed [GID-TA10765] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Ibrutinib with venetoclax for untreated chronic lymphocytic leukaemia or small lymphocytic lymphoma [ID3860]

Proposed [GID-TA10746] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Lenvatinib with pembrolizumab for untreated advanced or unresectable hepatocellular carcinoma [ID3930]

Proposed [GID-TA10811] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Lorlatinib for untreated ALK-positive advanced non-small-cell lung cancer [ID3896]

Proposed [GID-TA10812] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Trastuzumab deruxtecan for treating HER2-negative metastatic or unresectable breast cancer after chemotherapy [ID3935]

Proposed [GID-TA10813] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Trastuzumab deruxtecan for treating HER2-mutated unresectable or metastatic non-squamous non-small-cell lung cancer after 1 or more therapies [ID3934]

Proposed [GID-TA10814] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic gastric or gastro-oesophageal junction cancer after 2 or more therapies [ID3933]

Proposed [GID-TA10815] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Mosunetuzumab for treating relapsed or refractory B-cell non-Hodgkin lymphoma [ID3931]

Proposed [GID-TA10816] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Belzutifan for treating clear-cell renal carcinoma caused by von Hippel-Lindau disease [ID3932]

Proposed [GID-TA10817] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Tofacitinib for treating active ankylosing spondylitis [ID3865]

Proposed [GID-TA10771] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Tofacitinib for treating juvenile idiopathic arthritis [ID2718]

Proposed [GID-TA10706] Expected publication date: 20 October 2021

Type

Technology appraisal guidance

Status

Proposed
Cabotegravir and rilpivirine for treating HIV-1 [ID3766]

Proposed [GID-TA10658] Expected publication date: 20 October 2021

Type

Technology appraisal guidance

Status

Proposed
Ozanimod for treating moderately to severely active ulcerative colitis [ID3841]

Proposed [GID-TA10732] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Empagliflozin for treating chronic heart failure with reduced ejection fraction [ID3826]

Proposed [GID-TA10719] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Ibalizumab for treating adults infected with multidrug resistant HIV-1 for whom it is not possible to construct a suppressive anti-viral regimen [ID2720]

Proposed [GID-TA10657] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Selumetinib for treating inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 years and over [ID1590]

Proposed [GID-TA10535] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Foslevodopa-foscarbidopa for treating Parkinson's disease with motor fluctuations [ID3876]

Proposed [GID-TA10772] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Gefapixant for treating refractory or unexplained chronic cough [ID3789]

Proposed [GID-TA10678] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Benralizumab for previously treated severe nasal polyps [ID1659]

Proposed [GID-TA10818] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Risankizumab for previously treated active psoriatic arthritis [ID1399]

Proposed [GID-TA10819] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Finerenone for treating chronic kidney disease in people with type 2 diabetes [ID3773]

Proposed [GID-TA10820] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Dapagliflozin for treating chronic kidney disease [ID3866]

Proposed [GID-TA10808] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Avatrombopag in combination for treating chronic immune thrombocytopenia [ID3838]

Proposed [GID-TA10738] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Avatrombopag for treating chemotherapy-induced thrombocytopenia in non-haematological cancers [ID3837]

Proposed [GID-TA10737] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Burosumab for treating X-linked hypophosphataemia in adults [ID3822]

Proposed [GID-TA10733] Expected publication date: TBC

Type

Technology appraisal guidance

Status

Proposed
Microwave ablation for treating primary lung cancer and metastases in the lung

In development [GID-IPG10181] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Stereotactic radiosurgery for trigeminal neuralgia using the gamma knife

In development [GID-IPG10179] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Intramedullary distraction for lower limb lengthening

In development [GID-IPG10180] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Radiofrequency ablation for palliation of painful spinal metastases

In development [GID-IPG10158] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Magnetic resonance therapy for knee osteoarthritis

In development [GID-IPG10159] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Endobronchial vagal nerve ablation for chronic obstructive pulmonary disease

In development [GID-IPG10160] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Intramedullary distraction for upper limb lengthening

In development [GID-IPG10163] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Hysteroscopic morcellation of uterine leiomyomas (fibroids)

In development [GID-IPG10165] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Laparoscopic renal denervation

In development [GID-IPG10166] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Implanting a baroreceptor stimulation device for resistant hypertension

In development [GID-IP1180] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Lung transplantation with ex-vivo perfusion

In development [GID-IP1046] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer

In development [GID-IPG10205] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Prophylactic or therapeutic use of endoanchoring systems in endovascular aortic aneurysm repair (EVAR/TEVAR)

In development [GID-IPG10203] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Total hip arthroplasty using the superpath approach for osteoarthritis

In development [GID-IPG10204] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids

In development [GID-IPG10147] Expected publication date: 31 March 2021

Type

Interventional procedures guidance

Status

In development
Extracorporeal whole liver perfusion for acute liver failure

In development [GID-IPG10164] Expected publication date: 31 March 2021

Type

Interventional procedures guidance

Status

In development
Endoscopic balloon dilation for subglottic or tracheal stenosis

In development [GID-IPG10184] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Laparoscopic morcellation of uterine fibroids

In development [GID-IPG10185] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Endoscopic full thickness removal of gastrointestinal stromal tumours of the stomach

In development [GID-IPG10187] Expected publication date: TBC

Type

Interventional procedures guidance

Status

In development
Electrohydraulic lithotripsy for difficult-to-treat bile duct stones

In development [GID-IPG10151] Expected publication date: 28 April 2021

Type

Interventional procedures guidance

Status

In development